Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis

Insufficient platelet inhibition has been reported in up to 40% of aspirin-treated patients, including patients with essential thrombocytosis. To maintain sufficient platelet inhibition, a shorter dosing interval with aspirin has been suggested. We aimed to investigate the antiplatelet effect of low...

詳細記述

書誌詳細

出版年:	Platelets
主要な著者:	Mads Lamm Larsen, Oliver Heidmann Pedersen, Anne-Mette Hvas, Peter Buur van Kooten Niekerk, Søren Bønløkke, Steen Dalby Kristensen, Erik Lerkevang Grove
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2019-04-01
主題:	aspirin essential thrombocythemia platelet aggregation platelet turnover thrombocytosis thromboxane b2
オンライン･アクセス:	http://dx.doi.org/10.1080/09537104.2018.1430356